393 studies found for:    nasopharyngeal cancer | "Nasopharyngeal Carcinoma"
Show Display Options
Rank Status Study
21 Active, not recruiting Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Docetaxel, cisplatin and fluorouracil;   Radiation: Concurrent chemoradiotherapy
22 Active, not recruiting Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Cisplatin,fluorouracil;   Drug: Cisplatin
23 Active, not recruiting Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Cetuximab;   Drug: Cisplatin;   Drug: Docetaxel;   Radiation: Intensity-modulated radiotherapy
24 Recruiting Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: gemcitabine and cisplatin (Induction chemotherapy);   Radiation: IMRT and concurrent cisplatin
25 Recruiting The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: cisplatin
26 Completed Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Carcinoma;   Adverse Effect of Radiation Therapy;   Brain Necrosis
Interventions: Drug: bevacizumab;   Drug: Methylprednisolone
27 Recruiting Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Drug: Gemcitabine and cisplatin;   Drug: Cisplatin
28 Not yet recruiting Induction Chemotherapy With GP Versus TPF in the Treatment of Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: A combination of Gemcitabine and cisplatin;   Drug: A combination of Docetaxel, cisplatin and 5-Fluorouracil
29 Unknown  Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Gemcitabine;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: 5-fluorouracil (5-FU)
30 Not yet recruiting The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: One cycle TPF induction chemotherapy for NPC;   Drug: Three cycles TPF induction chemotherapy for NPC
31 Completed Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s)
Condition: Nasopharyngeal Carcinoma
Intervention:
32 Recruiting Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Capecitabine;   Drug: Adjuvant chemotherapy using PF (5-Fluorouracil );   Drug: Induction chemotherapy using PF (5-Fluorouracil)
33 Completed Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families
Condition: Nasopharyngeal Carcinoma
Intervention:
34 Completed
Has Results
Study of Cetuximab in Nasopharyngeal Carcinoma (NPC) With Chemoradiotherapy
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: C225 (cetuximab)
35 Unknown  Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: FOSCAN
36 Recruiting Dietary Nitrate on Plasma Nitrate Levels for Nasopharyngeal Carcinoma Patients
Condition: Nasopharyngeal Carcinoma
Interventions: Dietary Supplement: nitrate supplementation;   Dietary Supplement: Placebo
37 Recruiting Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma
Conditions: Chemoradiation;   Nasopharyngeal Carcinoma
Interventions: Drug: PF (cisplatin and 5-fluorouracil) group;   Drug: TPF (docetaxel plus cisplatin and 5-fluorouracil) group
38 Recruiting Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma
Conditions: Effects of Chemotherapy;   Stage IVC Nasopharyngeal Carcinoma
Interventions: Drug: Recombinant Human Endostatin plus gemcitabine and cisplatin;   Drug: Gemcitabine and cisplatin
39 Completed Swallowing Pattern of Patients With Nasopharyngeal Cancer Before and After Radiation Therapy: Longitudinal Study and Correction With Saliva Amount
Condition: Nasopharyngeal Carcinoma
Intervention:
40 Active, not recruiting Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Radiation: Proton/Photon Radiotherapy;   Drug: Cisplatin;   Drug: Fluorouracil

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years